Cosmo Pharmaceuticals NV (OTCPK:CMOPF)
$ 95 0 (0%) Market Cap: 1.19 Bil Enterprise Value: 1.04 Bil PE Ratio: 15.53 PB Ratio: 2.16 GF Score: 84/100

Full Year 2023 Cosmo Pharmaceuticals NV Earnings Call Transcript

Mar 20, 2024 / 10:00AM GMT
Release Date Price: $75.9 (+1.07%)
Alessandro Della Cha
Cosmo Pharmaceuticals N.V. - CEO & Executive Director

Preliminary unaudited full-year 2023 results. Just a little bit of housekeeping before we begin, I guessed that those that are on the call now know that there will be a much longer and detailed event here in Zurich, starting at 3:00 PM for which we have provided webcast links. We're going to have many people from Cosmo management team that will be presenting and will be ready to answer to any questions you might have.

So I don't think that this call right now is going to be the right venue to answer many of the questions that may come, because we would like the other managers and other people involved to answer more in detail and with the breadth and the depth that is required for in order to explain exactly how our business is faring and what are the developments underway. So here in this specific venue and today's call, now at 11:00 AM, we will be happy to take questions that are mainly technical and related to accounts so that we can talk about business products and perspective much more in detail in the afternoon

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot